Savara, Inc. (SVRA)

5.12 -0.12 (-2.29%) USD  |  NASDAQ  |  May 01, 16:00
5.12 0.00 (0.00%) After-Hours: 20:00
More

Savara EPS Diluted (Quarterly) : -0.1341 for Dec. 31, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for SVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Spyre Therapeutics, Inc. -0.6903
ACADIA Pharmaceuticals, Inc. 1.596
Alnylam Pharmaceuticals, Inc. 1.508
BioMarin Pharmaceutical, Inc. -0.2423
Imunon, Inc. -1.292

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -32.24M
Total Expenses (Quarterly) 32.24M
Enterprise Value 842.06M
Earnings Yield -10.44%
Normalized Earnings Yield -10.40